PATENT CLAIM ANALYSIS

Application Number: 15903514
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "457000"]

Abstract:
The invention relates to compositions and methods that include short chain fatty acids (SCFAs), related therapeutic compounds, and other compounds, including combinations thereof, for the treatment or prevention of diseases or disorders.

Claim (Index 22):
The method of  claim 14 , wherein the disease is a skin disease or disorder and further wherein the method comprises:\n administering a daily oral dose of at least 900 mg of butyrate, at least 100 mg propionate, and at least 10 mg apremilast in enteric coated, extended release capsules, 3 times/day for at least 2 weeks.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.18182
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14963521', '13310199', '15680629', '15171611', '14885084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7381892129320037
- 35 USC 102 Novelty (BERT): 0.5130490676134031
- Combined Prediction Score: 0.7156751984001437
- Mean Citation Score: 229.239214
- Max Citation Score: 253.6623
- Similarity Product: 154.47212261297105

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test